Cargando…

The value of BCG and TNF in autoimmunity /

"The Value of BCG and TNF in Autoimmunity provides an overview of current research and thinking related to tumor necrosis factor (TNF) induction and the use of the bacillus Calmette-Gu�erin (BCG) vaccine as potential treatment approaches to diverse forms of autoimmunity. BCG, commonl...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autor Corporativo: BCG and TNF Signaling in the Treatment and Prevention of Autoimmune Diseases London, England
Otros Autores: Faustman, Denise (Editor )
Formato: Electrónico Congresos, conferencias eBook
Idioma:Inglés
Publicado: London : Elsevier/Academic Press, [2014]
Temas:
Acceso en línea:Texto completo

MARC

LEADER 00000cam a2200000 i 4500
001 SCIDIR_ocn874321486
003 OCoLC
005 20231120111544.0
006 m o d
007 cr |||||||||||
008 140322t20142014enka ob 100 0 eng d
040 |a EBLCP  |b eng  |e rda  |e pn  |c EBLCP  |d OCLCQ  |d OPELS  |d N$T  |d OCLCF  |d OCLCQ  |d DEBSZ  |d MMU  |d OCL  |d FEM  |d OCLCO  |d MERUC  |d OCLCO  |d OCLCQ  |d CASUM  |d OCLCO  |d OCLCA  |d U3W  |d OCLCO  |d D6H  |d OCLCO  |d OTZ  |d OCLCQ  |d OCLCO  |d OCLCA  |d DCT  |d OCLCQ  |d OCLCO  |d S2H  |d OCLCO  |d COM  |d OCLCO  |d OCLCQ  |d OCL  |d OCLCO 
019 |a 968011337  |a 969015703 
020 |a 9780128004616  |q (electronic bk.) 
020 |a 0128004614  |q (electronic bk.) 
020 |z 9780127999647 
035 |a (OCoLC)874321486  |z (OCoLC)968011337  |z (OCoLC)969015703 
050 4 |a QR188.3 
060 4 |a 2014 F-677 
060 4 |a WD 305 
072 7 |a HEA  |x 039000  |2 bisacsh 
072 7 |a MED  |x 014000  |2 bisacsh 
072 7 |a MED  |x 022000  |2 bisacsh 
072 7 |a MED  |x 112000  |2 bisacsh 
072 7 |a MED  |x 045000  |2 bisacsh 
082 0 4 |a 616.97/8 
111 2 |a BCG and TNF Signaling in the Treatment and Prevention of Autoimmune Diseases  |n (1st :  |d 2013 :  |c London, England),  |j author. 
245 1 4 |a The value of BCG and TNF in autoimmunity /  |c [edited by] Denise L. Faustman. 
264 1 |a London :  |b Elsevier/Academic Press,  |c [2014] 
264 4 |c �2014 
300 |a 1 online resource (xv, 164 pages) :  |b illustrations (chiefly color) 
336 |a text  |b txt  |2 rdacontent 
336 |a still image  |b sti  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
504 |a Includes bibliographical references. 
505 0 |a Mycobacteria, immunoregulation, and autoimmunity -- Prevention of Type 1 Diabetes and its recurrence by immunotherapy with mycobacterial adjuvants -- Proteasome defects and cytokine signaling on Sjogren's syndrome -- The protective effect of the BCG vaccine on the development of Type 1 Diabetes in humans -- Effects of the bacillus Calmette-Gu�erin (BCG) vaccines in the demyelinating disease of the central nervous system -- TNF, BCG, and the proteasome in autoimmunity: an overview of the pathways & results of a phase I study in Type 1 diabetes -- Why test BCG in Sj�ogrens syndrome? -- Celiac disease as a model disorder for testing autoimmune therapeutics -- Delivering solutions and clinical benefits for diseases with small intermediate-size patient populations. 
520 |a "The Value of BCG and TNF in Autoimmunity provides an overview of current research and thinking related to tumor necrosis factor (TNF) induction and the use of the bacillus Calmette-Gu�erin (BCG) vaccine as potential treatment approaches to diverse forms of autoimmunity. BCG, commonly known as an anti-tuberculosis vaccine, is being explored in worldwide clinical trials as an approach to the treatment of certain forms of autoimmunity. The scope of research behind this therapeutic approach spans from the basic science of TNF signaling to research in diverse autoimmune disciplines, such as type 1 diabetes and multiple sclerosis. Overall, the book focuses on the lessons that can be learned from the researchers' individual experiences and data, and provides a rationale for bringing the inexpensive, generic BCG vaccine to the forefront of clinical trials in different forms of autoimmunity"--Publisher's description. 
588 0 |a Online resource; title from resource home page (ebrary, viewed March 7, 2016). 
650 0 |a Autoimmune diseases  |x Immunotherapy. 
650 0 |a BCG vaccines  |x Therapeutic use. 
650 0 |a Tumor necrosis factor. 
650 0 |a Autoimmunity. 
650 1 2 |a Autoimmune Diseases  |x therapy  |0 (DNLM)D001327Q000628 
650 1 2 |a BCG Vaccine  |x therapeutic use  |0 (DNLM)D001500Q000627 
650 2 2 |a Autoimmunity  |0 (DNLM)D015551 
650 2 2 |a Immunotherapy  |x methods  |0 (DNLM)D007167Q000379 
650 2 2 |a Tumor Necrosis Factors  |0 (DNLM)D048069 
650 6 |a Maladies auto-immunes  |0 (CaQQLa)201-0064242  |x Immunoth�erapie.  |0 (CaQQLa)201-0380098 
650 6 |a Auto-immunit�e.  |0 (CaQQLa)201-0060759 
650 6 |a Facteurs de n�ecrose tumorale.  |0 (CaQQLa)201-0203643 
650 7 |a HEALTH & FITNESS  |x Diseases  |x General.  |2 bisacsh 
650 7 |a MEDICAL  |x Clinical Medicine.  |2 bisacsh 
650 7 |a MEDICAL  |x Diseases.  |2 bisacsh 
650 7 |a MEDICAL  |x Evidence-Based Medicine.  |2 bisacsh 
650 7 |a MEDICAL  |x Internal Medicine.  |2 bisacsh 
650 7 |a Autoimmunity  |2 fast  |0 (OCoLC)fst00822674 
650 7 |a Autoimmune diseases  |x Immunotherapy  |2 fast  |0 (OCoLC)fst00822669 
650 7 |a BCG vaccines  |x Therapeutic use  |2 fast  |0 (OCoLC)fst00824856 
650 7 |a Tumor necrosis factor  |2 fast  |0 (OCoLC)fst01158755 
655 2 |a Congress  |0 (DNLM)D016423 
655 7 |a proceedings (reports)  |2 aat  |0 (CStmoGRI)aatgf300027316 
655 7 |a Conference papers and proceedings  |2 fast  |0 (OCoLC)fst01423772 
655 7 |a Conference papers and proceedings.  |2 lcgft 
655 7 |a Actes de congr�es.  |2 rvmgf  |0 (CaQQLa)RVMGF-000001049 
700 1 |a Faustman, Denise,  |e editor. 
776 0 8 |i Print version:  |a BCG and TNF Signaling in Autoimmunity (Conference) (2013 : London, England).  |t Value of BCG and TNF in autoimmunity.  |d Amsterdam : Elsevier, Academic Press, [2014]  |z 9780127999647  |w (DLC) 2012276564  |w (OCoLC)885014725 
856 4 0 |u https://sciencedirect.uam.elogim.com/science/book/9780127999647  |z Texto completo